Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Recent advances, difficulties and breakthroughs in the field of Nanomedicine
- Nanomedicine 2017

About

Allied Academies invites the contributors across the globe to participate in the premier “Global Meet on Nanomedicine & Toxicology” (Nanomedicine-2017), to discuss the theme: "recent advances, difficulties, and breakthroughs in the field of Nanomedicine” the conference will be held at New Orleans, USA, during November 06-07, 2017.

The main goal of the conference is to draw experts from across international and national academic community as well as the industry and to bridge the gap between industry and academia. Nanomedicine 2017 will strictly focus on the nano industry, Toxicology offering an exclusive combination of exhibits and scientific sessions. The event will provide an international forum for the exchange of technical information in a wide variety of branches of nanomedicine, nanotechnology,Toxicology and Genomics research, through feature workshops, and track sessions; plenary and invited talks from the world most renowned scientists and engineers; exhibition of software, hardware, equipment, materials, services and literature. The scientific sessions will enable the attendees to learn extremes. The conference program will cover a wide variety of topics relevant to the nanomedicine, including: Nanomedicine in drug discovery and delivery, Nanomedicine in Cancer Therapy, Toxicology, Toxicogenomics, applications of nanomedicine in healthcare applications and disease treatments.

Why to attend?

With members from around the world focused on learning about nanomedicine and toxicology; this is your best opportunity to reach the largest assemblage of participants from the Nanotechnology and Toxicology communities. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event.

Target Audience:

Nanomedicine Academia Professors , Medical professionals, Nanomedicine Department heads, Nanomedicine researchers, Nanomedicine CTOs, Nanomedicine product managers, Toxicologist, Toxicology department heads, business development managers, Entrepreneurs, Industry analysts, Investors, Students,  Media representatives and decision makers from all corners of Nanomedicine and Toxicology research area around the globe.

Market Analysis

Summary of Nanomedicine Conference:

Nanomedicine 2017 welcomes attendees, presenters, and exhibitors from all over the world to New Orleans, USA. We are delighted to invite you all to attend and register for the “Global Meet on Nanomedicine & Toxicology” which is going to be held during November 06-07, 2017 at New Orleans, USA. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Nanomedicine-2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Nanomedicine 2017 organizing committee look forward to meet in person.

Scope and Importance:

The emergence of Nanomedicine and Toxicology in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario. Some of the drivers of this market include increasing research funding, rising government support, improved regulatory framework, technological know-how and rising prevalence of chronic diseases such as diabetes, cancers, obesity, kidney disorders, Orthopedic diseases and others.

Market Analysis:

Global Nanomedicine market was valued at USD 212.0 billion in 2015. The advent of nanotechnology and its application in early diagnosis of diseases, preventive intervention, and prophylaxis of chronic as well as acute disorders is expected to serve as a fillip for nanomedicine market. Nanotechnology involves the miniaturization of larger structures and chemicals to a nanometric scale. Complete development and commercialization of the techniques that are expected to significantly revolutionize the administration of drugs, thus influencing adoption through to 2024.

The rise in investment by industry participants and government organizations in Nano robotics, a segment that is its nascent stage of development, is projected to witness substantial breakthrough advancements over the coming decade and is expected to provide lucrative avenues of growth. Scientists are attempting to engineer nano-robots that can be injected and can directly target and destroy leukemia and lymphoma cells in cancer patients, without affecting any nearby healthy tissue cells. Furthermore, ongoing research being carried out for building these bots using DNA origami is further expected to enhance potential through to 2024 by exhibiting potentially high-value medical avenues and opportunities.

The presence of several products in clinical and investigative pipeline phases is also anticipated to influence growth in the coming years owing to the commercialization of the finalized outcomes. Out of the different therapeutic products over 40% are in phase II of clinical development and can be expected to be commercialized by the earlier half of the coming decade, consequently impacting industrial progress in the near future.

This technology has also observed a significant demand in personalized medicine and therapy owing to their ability to treat patients based on customized treatments for genetic abnormalities and chronic disorders.  Moreover, the characteristic principle of nanomedicine that enables site-specific targeting and free movement across the blood-brain barriers facilitates its usage in diagnostics as well as therapeutics at the same time. This versatility associated with techniques under development in this market are expected to augment R&D investment in research projects in the sector consequently fuelling demand. 

Companies involved in Nanomedicine:

GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories are some of the major companies in the Nanomedicine market. 

Why to attend?

With members from around the world focused on learning about Nanomedicine and Toxicology this is your single best opportunity to reach the largest assemblage of participants from all over the world. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 2-day event.

World-renowned speakers, the most recent techniques, tactics, and the newest updates in the field of Nanomedicine, Nanotechnology,Toxicology and tissue engineering are hallmarks of this conference. Nanomedicine-2017 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent researches on Nanomedicine, Nanotechnology, Material Science and other interesting topics..

 

Members associated with Nanomedicine:

Eminent Scientists, Research Professors, Rectors

Marketing Professionals, Regulatory Officials, Engineers

Students and research scholars

Members of different medical associations

Governmental and public bodies

Advocacy groups, Institutional Board members

 

Top Universities in the world:

Duke University

University of Pennysylvania

John Hopkins University

Stevens Institute of technology

Washington state university

Virginia Commonwealth University

 

INTENDED AUDIENCE

The report is especially intended for entrepreneurs, investors, venture capitalists, and other readers with a need to know where the nanomedicine market is headed in the next 5 years. Other readers who should find the report particularly valuable include nanotechnology marketing executives and government officials associated with the National Nanotechnology Initiative and other state-level programs that promote the development of the nanotechnology industry and the people related to Toxicology. The report’s findings and conclusions should also be of interest to the broader nanotechnology community. World-renowned speakers, the most recent techniques, tactics and the newest updates along with the Advances in the fields of Nanomedicine, Nanotechnology & Toxicology.

Come be a Part of it...!

Session and Tracks

Track 1:- Nanomedicine and Drug delivery

Nanoparticle technology was recently shown to hold great promise for drug delivery applications in nanomedicine due to its beneficial properties, such as better encapsulation, bioavailability, control release, and lower toxic effect. Despite the great progress in nanomedicine, there remain many limitations for clinical applications on nanocarriers. To overcome these limitations, advanced nanoparticles for drug delivery have been developed to enable the spatially and temporally controlled release of drugs in response to specific stimuli at disease sites. Furthermore, the controlled self-assembly of organic and inorganic materials may enable their use in theranostic applications. This review presents an overview of a recent advanced nano particulate system that can be used as a potential drug delivery carrier and focuses on the potential applications of nanoparticles in various biomedical fields for human health care.

Track 2:- Nano medicine & Nano biotechnology

Nanomedicine can be defined as medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices, Nano electronic devices &biosensors and possible future applications of molecular nanotechnology. Nanomaterials can be functionalized to interface with biological molecules & structures as the size of nanomaterials is comparable to most biological molecules and structures. Nanomaterials can be useful for both in vivo and in vitro biomedical research and applications and integration of nanomaterials with biology has led to the development of advanced diagnostic devices, physical therapy applications, analytical tools, contrast agents and drug delivery vehicles. Nanomedicine strives for delivering valuable set of research tools & clinically useful devices and its industry sales reached $16 billion in 2015, with an average of $3.8 billion investment in nanotechnology R&D every year and increase of 45% per year global funding for emerging nanotechnology.

Track 3:- Nanomedicine in Cancer Therapy

Cancer is the second leading cause of mortality, after heart attack. By 2020 there will be increase in the number of new cases by 15 million. Nanotechnology is used for both targeted drug delivery and intrinsic therapies. Nano particles are directly injected into the tumor and are activated to produce heat and destroy the cells of the tumor either by x-ray, light or Magnetic field. Gold Nano rods are being used to carry chemotherapy drugs into the tumor and locally excite it by infrared rays. The heat induced is helpful to destroy cells of tumor as well as encapsulate drugs.

Track 4:-Nanomedicine in Healthcare

Nano medicine affects almost all the aspects of healthcare. Nano medicine helps to engineer novel and advanced tools for the treatment of various diseases and the improvement of human bio systems using molecular Nanotechnology. Cardiovascular diseases, Neurodegenerative disorders, Cancer, Diabetes, Infectious diseases, HIV/AIDS are the main diseases whose treatment can be benefitted by using Nano medicine.

Track 5:- Nanotechnology in Medicine

The use of nanotechnology in medicine offers some exciting possibilities. Some practices are only imagined, while others are at various stages of testing, or actually being used today. Nanotechnology in drug involves applications of nanoparticles currently under development, as well as longer ranges exploration that involves the use of manufactured nano-robots to make maintenances at the cellular level (sometimes referred to as nanomedicine)

 Track 6:- Nano Pharmaceuticals

Pharmaceutical Nanotechnology for Drug Delivery using Nanotechnology session plays major role in the future of pharmaceutical research. In this session, we will go over several of the most important features of nanotechnology, anticancer drug developmentpharmocology of cancer drugs, that will impact our lives but we will also talk about what nanotechnology itself will be like in the future and Investigator specifically from cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient.

Track 7:- Nano Chemistry

Nanochemistry is the combination of chemistry and nanoscience. Nanochemistry is related by synthesis of building blocks which are dependent on size, surface, shape and defect properties. Nanochemistry is being used in chemical, physical and materials science as well as engineering, biological and medical applications. Nanochemistry and other nanoscience fields have the same core concepts but the usages of those concepts are different. Nano-construct synthesis is dependent on how the surface, size and shape will lead to self-assembly of the building blocks into the functional structures; they probably have functional defects and might be useful for photonic, electronic, medical or bioanalytical problems.

Track 8:- Nano Cosmetology

Nano cosmetology has applications including hair care products; make up, sunscreens and Moisturizers. Nano Cosmetics contains Liposomes and niosomes as delivery vehicles. Newer structures such as solid lipid nanoparticles and nanostructured lipid carriers have been found to perform better than liposomes. Nanostructured lipid carriers have been identified as a potential next generation cosmetic delivery agent that can boost skin hydration, bioavailability, stability of the agent and controlled occlusion. Encapsulation techniques have been proposed for carrying cosmetic actives. In cosmetic applications, nanocrystals and nanoemulsions are being investigated.

Track 9:- Toxicology

 Toxicology is a branch which deals with biologychemistry, and medicine concerned with the study of the adverse effects of chemicals on living organisms. Toxicology studies the harmful effects of biological, chemical and physical agents in biological systems which establishes the extent of damage in living organisms. The relationship between dose and its effects on any exposed organism is of high significance in toxicology. Factors that influence toxicology include the dosage the route of exposure, the species, age, sex and environment.

Track 10:- Biomarkers

biomarker is introduced into an organism as a means to examine organ function or other aspects of health. Most of the biomarkers are relatively easy to measure and involve in repetitive medical examinations. Biomarkers help in knowing and differentiating the normal human beings from disease attack once. The following biomarkers like inflammatory markers, RNA biomarkers, cancer biomarkers, radiation biomarkers, biomarkers of petroleum products and mixture toxicity play a prominent role.

Track 11: Tissue Engineering and Regenerative Medicine

 Tissue engineering is emerging as a significant potential alternative or complementary solution, whereby tissue and organ failure is addressed by implanting natural, synthetic, or semisynthetic tissue and organ mimics that are fully functional from the start or that grow into the required functionality. Initial efforts have focused on skin equivalents for treating burns, but an increasing number of tissue types are now being engineered, as well as biomaterials and scaffolds used as delivery systems. A variety of approaches are used to coax differentiated or undifferentiated cells, such as stem cells, into the desired cell type. Notable results include tissue-engineered bone, blood vessels, liver, muscle, and even nerve conduits.

                                  Regeneration is the process of renewal, restoration, and growth that makes genomes, cells, organisms, and ecosystems resilient to natural fluctuations or events that cause disturbance or damage. Every species is capable of regeneration, from bacteria to humans. Regeneration can either be complete where the new tissue is the same as the lost tissue, or incomplete where after the necrotic tissue comes fibrosis. Now a day its market is quiet high.

 Track 12:- Toxicogenomics

Toxicogenomics is the branch of science dealing with the collection, interpretation and storage of information about protein and gene activity within the cell or tissue of an organism in response to toxic agents. Studying these mechanisms can aid in building better animal and human models, with the goal of better predicting toxic response in humans. The field of toxicogenomics relates global mRNA, protein and metabolite analysis related technologies to study the effects of hazards on organisms. Toxicogenomics studies of proteins can be done by protien mass spectrometry.

Track 13:- Toxicologic Pathology

Toxicologic Pathology is dedicated to human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology. Toxicologic Pathology includes safety assessment of pharmaceuticals, chemicals, food additives, pesticides, environmentally relevant chemicals, and medical devices; risk characterization of xenobiotics, the investigative studies that contribute to refinement of the safety assessment process; mechanistic studies that provide a basis for interpreting and predicting toxicologic outcome; emerging approaches and methods in toxicologic pathology; spontaneous diseases that may influence toxicology studies, and animal and alternative models relevant to toxicologic pathology.

Track 14:- Toxicovigilance

Pharmacovigilance which is mainly known as Drug Safety, is a pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. Toxicovigilance mainly focuses on adverse drug reactions, the toxic effects of synthetic and natural chemicals on the biological systems

 Track 15:- Chemical Weapon

chemical weapon (CW) is a specialized munition that uses chemicals formulated to cause death or harm on humans. Munitions or other delivery devices designed to deliver chemical weapons, whether filled or unfilled, are also considered weapons themselves. Chemical weapons are distinct from radiological weapons, biological weapons, and nuclear weapons. All may be used in warfare and are known by the military acronym NBC (for nuclear, biological, and chemical warfare). Weapons of mass destruction are distinct from conventional weapons, which are primarily effective due to their explosive, kinetic, or incendiary potential. Chemical weapons can be widely dispersed in gas, solid and liquid forms, and may easily afflict others than the intended targets. Pepper spray, Nerve gas and tear gas are three modern examples of CW.

Track 16: Material Science Engineering

Materials science and engineering, is a discipline which deals with the discovery and design of new substances. The research in material technological know-how includes in Transmission electron microscopy in cutting-edge substances technological know-how, advancements of materials technological know-how, Mining and metallurgy, power substances there are 50 universities and a marketplace to growth of 5.1% over the duration 2014-2019. The strength materials marketplace changed into predicted to be $7,292.eight million in 2014 and is projected to boom of 7.8% from 2014 to 2019.

 

Organizing Committee
OCM Member
Manijeh Razeghi
Professor and Director , Quantum Devices
Northwestern University
Chicago, USA
OCM Member
Hicham Fenniri
Professor, Chemical Engineering
The Northeastern Supramolecular Nanomaterials Lab
Boston, USA
OCM Member
Shaker A. Mousa
Executive Vice President and Chairman, Pharmacy
Pharmaceutical Research Institute
New York, USA
OCM Member
Orlando Auciello
Distinguished Chair, Materials Science and Engineering and Bioengineering
University of Texas at Dallas
Dallas, USA
OCM Member
Karuppasamy Gurunathan
Professor & Head, Nano science & Technology
Alagappa University
Karaikudi, India
OCM Member
Esmaiel Jabbari
Professor and Director of Biomaterials, Chemical and Biomedical Engineering
University of South Carolina
Columbia, USA
OCM Member
S. Joseph Antony
Associate Professor, School of Chemical and Process Engineering
University of Leeds
London, United Kingdom

To Collaborate Scientific Professionals around the World

Conference Date November 6-7, 2017
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality

New Orleans, USA

Join The Discussion

Mail us at

Nanomedicine 2017
nanomedicine@alliedconferences.org
Nanomedicine 2017
nanomedicine.allied@gmail.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.